02279 YONGHE MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.55X | Oper Margin | 7.1% |
|---|---|---|---|
| LT Debt/Equity | 46.3% | Net Margin | 4.1% |
| Total Debt/Equity | 61.5% | Return on Equity | 9.4% |
| Price/Book | 1.11X | Return on Assets | 4.3% |
| (HKD 1.860) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 82.05 | -240.72 | -592.83 | -94.15 | 143.80 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +134.1 | +59.4 | -529.6 | -165.5 | -17.6 |
| Earnings Per Share (HKD) | 0.164 | -0.481 | -1.194 | -0.184 | 0.359 |
| Earnings Per Share Growth (%) | +134.1 | +59.8 | -550.4 | -151.2 | -22.7 |
| Dividend Per Share (HKD) | 0.086 | No dividend | No dividend | No dividend | 0.093 |
| P/E* (X) | 11.34 | N/A | N/A | N/A | 5.18 |
| Yield (%) | 4.62 | N/A | N/A | N/A | 5.00 |
| Dividend Share (%) | 52.44 | N/A | N/A | N/A | 25.92 |
| Book NAV (HKD) | 1.670 | 1.446 | 1.971 | 3.372 | 3.995 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,808 | 1,804 | +0.2 | 1,777 |
| Operating Result | 105.449 | -203.512 | -151.8 | -532.87 |
| Profit Before Taxation | 105.449 | -255.291 | -141.3 | -585.219 |
| Taxation | 31.887 | -28.722 | -211.0 | -38.535 |
| Profit /( Loss) After Taxation | 73.562 | -226.569 | -132.5 | -546.684 |
| Minority Interests | -0.149 | -0.226 | -34.1 | -0.29 |
| Net Profit | 73.711 | -226.343 | -132.6 | -537.864 |
| Earnings Per Share () | 0.1640 | -0.4807 | -134.1 | -1.1942 |
| Dividend Per Share () | 0.0860 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2026-03-31 | 2025-03-27 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
